gt201
Cell therapyexperimental
Clinical trial activity
9 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
5
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Jan 4, 2022 (NCT05430360)
Timeline
2020s
- Jan 1, 2022
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Tumor antigensImmunity, passive
immunity, passive - tumor antigens
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06519669 | N/A | Jul 18, 2024 | Grit Biotechnology |
| NCT06190275 | N/A | May 12, 2024 | Grit Biotechnology |
| NCT06235242 | N/A | Feb 2, 2024 | Grit Biotechnology |
| NCT06144671 | Phase 1/Phase 2 (Phase 2) | Sep 13, 2023 | Grit Biotechnology |
| NCT06191900 | N/A | Jun 5, 2023 | Grit Biotechnology |
| NCT05724732 | Early Phase 1 (Phase 1) | Feb 1, 2023 | Jiao Tong University |
| NCT06834542 | Early Phase 1 (Phase 1) | Nov 1, 2022 | Grit Biotechnology |
| NCT05729399 | Early Phase 1 (Phase 1) | Sep 14, 2022 | Grit Biotechnology |
| NCT05430360 | Phase 1 | Jan 4, 2022 | Grit Biotechnology |
Showing 9 of 9 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Grit Biotechnology | For profit | 8 | 8 | 3 | 2022 |
| Jiao Tong University | Academic/Hospital | 1 | 1 | 1 | 2023 |
2 organizations
Page 1 / 1